RE:RE:XLY market share.nortzy27 wrote: fumbles thanks ,hence the expansion,however when they built there manufacturing plants ,why under build?,why the high burn rate?,they are better off getting some one who can add,dont spend like drunkin soilders,too many managers and freebees ,will they be provtable and survive is my question to you ,i wish i bought indiva ,i hope im wrong
General, selling and administrative expences were $50million in 2019, up from $48million in 2018.
There ongoing cash burn is about $12.5million per quarter. I think this is very reasonalble for the size of the company and number to seperate entities they own.
All this other money they have spent has been building facilities and going through the licences process for many seperate companies. These one time expences/investments are pretty much complete. The only other one time cash costs in the next 12 months will likley be the expansion and automation of Dosecann. Money I think will be well spent.
A big number I will be looking at in the Q1 financials aside from revenue is cash balance. They should still have $35-40million in the bank with the added revenue coming in and the lower cash costs.
They are a lot closer to break even cash flow then some on here would lead you to believe. I think Q2 could be a break even quarter after a small loss in Q1.